CURRICULUM VITAE

                                              Scott M. Bradfield, M.D., M.B.A.           

PERSONAL DATA

Address:                                                                                                67 Nantucket Island Court, Ponte Vedra, FL 32081

Place of Birth:                                                                                       Palm Beach Gardens, Florida

Marital Status:                                                                                      Married – Wife, Lissi Bradfield

Children:                                                                                               Son - Cameron Bradfield, born 2002

                                                                                                                Daughter - Lillian Bradfield, born 2005

                                                                                                            Son – Quinn Bradfield, born 2007                                                                                                                                                   

PRESENT POSITION

Associate Division Chief                                                                                                                    2012 - Present

Interim Division Chief                                                                                                                        2021 - 2023

Attending Physician                                                                                                                            2003 - Present

Nemours Children's Health - Jacksonville / Wolfson Children’s Hospital

Department of Pediatric Hematology/Oncology

807 Children’s Way

Jacksonville, FL  32207

(904) 697-3793

Medical Director, C.H.A.T. Adolescent and Young Adult Oncology Program                       2012-Present

Nemours Children’s Specialty Care

EDUCATION

Master of Business Administration,                                                                                                 2014

Concentration in Medical Management

University of Massachusetts-Amherst

Isenberg School of Management

Amherst, Massachusetts

Doctor of Medicine                                                                                                                             1997

University of South Florida, College of Medicine

Tampa, Florida

Bachelor of Science                                                                                                                            1993

Duke University

Durham, North Carolina   

POSTDOCTORAL TRAINING

Children’s Hospital and Regional Medical Center

Pediatric Service                                                                                                                                  1997 – 2000   

Massachusetts General Hospital

Boston, Massachusetts

BOARD CERTIFICATION(S)

American Board of Pediatrics Maintenance of Certification                                                         2005 – ongoing

Subspecialty in Pediatric Hematology/Oncology

Diplomate of the American Board of Pediatrics                                                                            2000 – ongoing                                                                               

LICENSURE AND CERTIFICATION

Institute for Healthcare Improvement: Basic Certificate

In Quality and Safety                                                                                                                          2019

Florida Medical License, Board of Health       #ME 88124                                                           2003 – Present                                                     

Drug Enforcement Administration certificate                                                                                  2003 – Present

License to Practice Medicine and Surgery     #MD00038695                                                    2000 – 2005

Department of Health, State of Washington                 

Certificate of Limited Registration                                                                                                  1997 – 2000    

Board of Registration in Medicine, Massachusetts

HONORS/AWARDS

2023 Student Teaching Apple Award for top faculty recognized for                                        2023

Outstanding teaching by the medical students

Castle Connolly Regional Top Doctor Award                                                                               2014, 2021

Jacksonville Magazine, Top Docs                                                                                                    2017, 2019

Physician Leadership Development Program, Nemours                                                              2017-2018

Phi Kappa Phi inductee,                                                                                                                     2014

Collegiate Honor Society

University of Massachusetts, Amherst chapter

Beta Gamma Sigma inductee,                                                                                                           2014

International Honor Society for Business Programs

University of Massachusetts, Amherst chapter

Highest Patient Satisfaction Score for 2010 for all Nemours                                                      2011

Children’s Clinic Physicians in Florida

Merit Award, American Society of Clinical Oncology                                                                   2003

2003 Annual Meeting

Doctor’s Doctor Award, The 4th year Medical Student the graduating                                       1997

class would most like to have as their own doctor

Director’s Award, H.Lee Moffitt Cancer Center                                                                             1997

The most promising 4th year medical student entering Academic Oncology

Pediatric Clerkship Award, Top 3rd year student in Pediatrics                                                     1997

Award for Academic Excellence                                                                                                       1997

4th year student ranked in the top 20 in the graduating class

Alpha Omega Alpha Honor Medical Society, Junior year inductee                                             1996

ACADEMIC APPOINTMENTS   

Assistant Professor in Pediatrics, Mayo Clinic College of                                                        2007-Present

Medicine, Rochester, Minnesota

Courtesy Assistant Professor in Pediatrics, University of Florida College of

Medicine – Jacksonville, Jacksonville, Florida                                                                                2011-Present

Instructor in Pediatrics, Mayo Clinic College of Medicine,                                                        2005 –2007      

Rochester, Minnesota                                     

Senior Fellow, Fred Hutchinson Cancer Research Center                                                           2001 – 2003    

Seattle, Washington

Fellow, University of Washington Medical Center                                                                      2000 – 2003     

Clinical Fellow in Pediatrics, Harvard Medical School                                                1997 – 2000    

Boston, Massachusetts

HOSPITAL STAFF PRIVILEGES

Associate Division Chief, Pediatric Hematology/Oncology                                                          2012 - Present

Attending Physician, Pediatric Hematology/Oncology,                                                              2003 - Present

Nemours Children’s Specialty Care, Jacksonville, FL

Pediatric Hematology/Oncology Section Chief                                                                             2010 - Present                                     

Attending Physician, Pediatric Hematology/Oncology,                                                               2003 - Present

Wolfson Children’s Hospital, Jacksonville, FL

Attending Physician, Pediatric Hematology/Oncology,                                                              2003 - 2013

Shands - Jacksonville Medical Center, Jacksonville, FL

PROFESSIONAL MEMBERSHIPS AND SOCIETIES

American College of Physician Executives, Member                                                                  2008 – 2010

Nemours Center for Childhood Cancer Research, Member                                                        2008 - Present

Children’s Oncology Group, Full Member                                                                                    2003 - Present

American Society of Hematology, Associate Member                                                                 2003 – 2011, 2015

American Society of Pediatric Hematology/Oncology, Associate Member                            2001 – Present

Medical Board, Wolfson Children’s Hospital

• Secretary                                                                                                               2013 - 2016
• Chief-of-Staff Elect                                                                                             2017 - 2018
• Chief-of-Staff                                                                                                       2019 – 2020
• Immediate Past Chief-of-Staff                                                                           2021 - 2022

Co-Chair, EPIC Oncology transition team, Wolfson Children’s Hospital                                   2021- 2022

Member, Nemours Children’s Specialty Care – Jacksonville,                                                      2011 – 2017

                Physician Satisfaction Committee

Core Member, WolfPAC, Wolfson Children’s Hospital,                                                               2010 - 2012

 EMR Physician Advisory Committee

Chair, Nemours Children’s Specialty Care – Jacksonville,                                                           2014 – 2020

                Fellowship Clinical Competency Committee

                Member, Fellowship Clinical Competency Committee                                                 2014 - Present

Member, Nemours Children’s Clinic KidsHealth / Getwell:)network Cancer

 Advisory Committee                                                                                                          2008 - 2011

Member, Nemours Children’s Clinic Safety Committee                                                                2006 - 2010

Chairman, Cancer Committee, Nemours Children’s Specialty Care - Jacksonville/              2005 – Present

                Wolfson Children’s Hospital

Member,   Ethics Committee, Wolfson Children’s Hospital                                                       2004-2009, 2011- Present 

Chairman, Ethics Committee, Wolfson Children’s Hospital                                                      2004 - 2009

Chairman, Nemours Children’s Specialty Care - Jacksonville/Wolfson Children’s               2010 - 2021

                Hospital Steering Committee

Member, Nemours Children’s Specialty Care - Jacksonville/Wolfson Children’s                      2003 - 2021

Hospital Steering Committee

Member, Pharmacy and Therapeutics Committee, Wolfson Children’s Hospital                  2003 – Present

Dreams Come True Board of Directors, Member                                                                         2008 - Present

American Cancer Society, Duval Unit, Operating Board, Member                                           2008 - 2013

Pediatric Bioethics Conference organizing committee                                                                2008

PedsCare / Community Hospice Reflective Practice Task Force                                               2005

Jacksonville Community Caring for Children Coalition Member – General coalition,         2004 - 2005

Steering committee and Education sub-committee

______________________________________________________________________________________________

LABORATORY EXPERIENCE

Senior Fellow, Fred Hutchinson Cancer Research Center, Seattle, WA                                   2001 – 2003

Fellow in Jerald Radich’s Experimental Pathology lab studying minimal

residual disease in leukemia, concentrating on monitoring WT1 as leukemic

marker, searching for novel MRD markers and documenting graft vs. leukemia

effect in ALL patients post-transplant.

1. Principal Investigator for Nemours Children’s Specialty Care- Jacksonville,                     2013 - Present

 Children’s Oncology Group cooperative group. NCI National Community

 Oncology Research Program (NCORP) Award [5 UG1 CA189958-08

 PI: Caywood, Emi]

2. Institutional Principal Investigator, NIH Subaward out of SickKids.                                   2021 – 2023

 Symptom Screening Linked to Care Pathways for Children with Cancer:

 a Cluster Randomized Trial. [R01CA251112-01; PJT-169165  PI Sung, Lillian]

3. Implementing Family Psychosocial Risk Screening for Pediatric Health Equity.              2023

[RSG-19-122-01-CPPB  PI Kazak, Anne]

4. Lead Investigator [Florida sites] in Cancer Care Delivery Research (CCDR)                    2014 – 2019

Delivery Research (CCDR) for the Nemours NCORP.  NCI National Community

Oncology Research Program (NCORP) Award [1 UG1 CA189958-01 PI: Sandler, Eric]

5. National Study Chair, Study Principal Investigator, HLMCC0402/ACCL0731                2007-2014

“Glutamic Acid to Decrease Vincristine Toxicity in Children with Cancer”

6. Institutional Principal Investigator, ARIAD AP23573-07-110, “A Multi-                        2008-2010

Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669)

Administered QDx5 Every Other Week in Pediatric Patients with Advanced

Solid Tumors”

7. Institutional Principal Investigator, Pfizer A1501088, “An Open-Label,                            2008-2009

Intravenous to Oral Switch, Multiple Dose Study to Evaluate the Pharmaco-

Kinetics, Safety and Tolerability of Voriconazole in Immunocompromised

Children Aged 2 to <12 Years Who are at High Risk for Systemic Fungal

Infection”

8. Institutional Prinicipal Investigator, "A Phase I Study of Irinotecan and                          2010-2016

Bevacizumab with Temozolomide in Children with Recurrent/Refractory

Central Nervous System Tumors."  

9. Co-investigator,  “Clinician-Parent-Patient Communication in Pediatrics:                       2011-2013

Cancer substudy, “ a Nemours Foundation internally-funded study.

______________________________________________________________________________________________

RESEARCH FUNDING

1. Title: Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial (SPARK).

Major Goals: Among children with newly diagnosed cancer, to determine if symptom screening and feedback to healthcare providers at least three times weekly and locally-adapted symptom management care pathways, when compared to usual care.

Project Number: R01CA251112-01   Name of PD/PI: Scott Bradfield, MD

Source of Support: The Hospital for Sick Children and NIH

Project/Proposal Start and End Date: (MM/YYYY) (if available): 08/2020 – 04/2025

Total Award Amount (including Indirect Costs): Per case reimbursement ($1,300 per patient)

Person Months (Calendar/Academic/Summer) per budget period= 0.12 person-month/annually

2. Title: Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial (SPARK).

Major Goals: Among children with newly diagnosed cancer, to determine if symptom screening and feedback to healthcare providers at least three times weekly and locally-adapted symptom management care pathways, when compared to usual care.

Project Number: PJT-169165    Name of PD/PI: Scott Bradfield, MD

Source of Support: The Hospital for Sick Children and the Canadian Institutes of Health Research (CIHR)

Project/Proposal Start and End Date: (MM/YYYY) (if available): 04/2020 – 03/2025

Total Award Amount (including Indirect Costs): Per case reimbursement ($750 per patient)

 Person Months (Calendar/Academic/Summer) per budget period= 0.12 person-month/annually

3. Title: Implementing Family Psychosocial Risk Screening for Pediatric Health Equity

Major Goals: The goal of this study is to create and broadly disseminate an implementation toolkit to facilitate acceptable, feasible, and sustainable family psychosocial risk screening in English and Spanish. The PAT will be implemented across a national sample of 18 pediatric cancer programs in a comparative effectiveness study.

Project Number: RSG-19-122-01-CPPB      Name of PD/PI: Kazak, A.E.

Source of Support: American Cancer Society

Project/Proposal Start and End Date: (MM/YYYY) (if available): 1/1/2020 – 12/31/2024

 Total Award Amount (including Indirect Costs): $37,558

 Person Months (Calendar/Academic/Summer) per budget period=0.84 person-month/annually

4. Title: Randomized phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML

Major Goals: Fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax clinical trial

Project Number: ITCC-101/APAL2020D     Name of PD/PI: Scott Bradfield, MD

Source of Support: LLS Pedal Initiative, LLC

Project/Proposal Start and End Date: (MM/YYYY) (if available): 11/2022 -

Total Award Amount (including Indirect Costs): Per case reimbursement (Arm A $135,783 per patient, Arm B $150,200 per patient)

 Person Months (Calendar/Academic/Summer) per budget period=0.12 person-month/annually

IN-KIND

5. Summary of In-Kind Contribution: Nemours NCI Community Oncology Research Program (NCORP) and Cancer Care Delivery Research PI

Project/Proposal Start and End Date (MM/YYYY) (if available): 08/2019 – 07/2025

Person Months (Calendar/Academic/Summer) per budget period =1.2 person-months/annually

Estimated Dollar Value of In-Kind Information: $141,270

1. Bradfield SM, Douglas JG, Hawkins DS, Sanders JE, Park JR. Fractionated low-dose radiotherapy following

 myeloablative stem cell transplant is an effective mode of local control in high-risk neuroblastoma. General Poster Session, ASCO 39^th Annual Meeting, May 31, 2003. Poster: Scott Bradfield.

2. Hawkins DS, Bradfield S, Whitlock JA, Krailo M, Franklin J, Blaney SM, Adamson PC, Reaman G.  Phase II study of

21-day continuous intravenous infusion (CIVI) topotecan for recurrent pediatric solid tumors: a Children’s Oncology Group Study (COG A09713). Poster Discussion Session, ASCO, 41^st Annual Meeting, May 16, 2005. Poster: Scott Bradfield.

3. Agarwal V, Logie N, Morris C, Bradley J, Rotondo R, Bradfield S, Indelicato DJ. Esophagitis in the Multimodality Treatment of Thoracic Ewing Sarcoma: Incidence, Risk Factors, and Management. Poster session, American Society of Pediatric Hematology/Oncology Annual Meeting – ASPHO, Montreal, Canada, April 26-29, 2017.

4. McManus K, Zorrilla J, Scimeme J, Bradfield S. A Hidden Osteomyelitis Leading to Deep Venous Thrombosis and Pulmonary Embolism Confounded by Recent Trauma. Poster, Southern Society for Pediatric Research, New Orleans, LA, February 21-23, 2019.

5. Indelicato DJ, Rotondo RL, Mailhot R, Uezono H, Bradfield S, Agarwal V, Hol ML, Bradley JA “Treatment Outcomes Following 45 GyRBE in Children with Group III Orbital Embryonal Rhabdomyosarcoma.”. American Society for Radiation Oncology (ASTRO), Annual Meeting, Chicago, IL, September 15-19, 2019.

6. Indelicato DJ, Rotondo RL, Mailhot R, Uezono H, Bradfield S, Agarwal V, Hol ML, Bradley JA. “Treatment Outcomes Following 45 GyRBE in Children with Group III Orbital Embryonal Rhabdomyosarcoma.” Pediatric Radiation Oncology Society (PROS) Annual Meeting, Bangkok, Thailand, June 19-22, 2019.

7. Kharod SM, Indelicato DJ, Rotondo RL, Mailhot RV, *Uezono H, Morris C, Bradfield S, Sandler E, Bradley JA. Outcomes Following Proton Therapy for Ewing Sarcoma of the Cranium and Skull Base. American Society for Radiation Oncology (ASTRO), Annual Meeting, Digital Poster Question and Answer Session. Chicago, IL, September 15-19, 2019.

8. Indelicato DJ, Mailhot Vega RB, Viviers E, Morris C, Bradfield S, Aldana PR, Bradley JA. Modern Therapy for Spinal and Paraspinal Ewing Sarcoma: an Update of the University of Florida Experience. 53^rd Congress of the International Society of Paediatric Oncology (SIOP), Virtual, October 24, 2021.

9. Johnson MC, Bradley JA, Mailhot Vega R, Bradfield S, Morris C, Indelicato. Outcomes in Pediatric NRSTS Treated with Proton Radiotherapy. 54^th Congress of the International Society of Paediatric Oncology (SIOP), Oral Presentation, Barcelona, Spain, September 29, 2022.

10. Giap F, Indelicato DJ, Mailhot Vega R, Morris C, Bradfield SM, Bradley JA. Local control for large unresectable intermediate risk pediatric rhabdomyosarcomas. American Society for Radiation Oncology (ASTRO), Annual Meeting, Quick Pitch presentation, San Antonio, TX, October 24, 2022.

11. Fortune EC, Indelicato DJ, Mailhot Vega RB, Bradfield SM, Bradley JA. Outcomes following Proton Radiotherapy for Pediatric Salivary Gland Tumors. American Society for Radiation Oncology (ASTRO), Annual Meeting, Poster Presentation, San Antonio, TX, October 23-26, 2022.

1.  Wright JA, Bradfield SM, Park JR, Hawkins DS. Prolonged survival after invasive aspergillosis: a single

institution review of eleven cases.  J Pediatr Hematol Oncol 2003; 25: 286-291. PMID: 12679641

2. Bradfield SM, Douglas JG, Hawkins DS, Sanders JE, Park JR.  Fractionated low-dose radiotherapy after

myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.  Cancer

2004; 100: 1268-1275. PMID: 15022296.

3. Hawkins DS, Bradfield S, Whitlock JA, Krailo M, Franklin J, Blaney SM, Adamson PC, Reaman G. 

Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: A Children’s

Oncology Group Study. Pediatr Blood Cancer 2006; 47(6): 790-794. PMID: 16435380.

4. Swota AH, Bradfield SM. “STOP” –ping Harm: When is State Intervention Justified? Pediatr Blood Cancer

 2010; 54(1): 8-10. PMID: 19902558.

5. Driscoll TA,  Yu LC, Frangoul H, Krance RA, Nemecek E, Blumer J, Arrieta A, Graham ML, Bradfield SM, Baruch A,

Liu P. Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults. Antimicrob Agents Chemother. 2011;55(12):5770-9. PMID: 21968355.

6. Bradfield SM, Sandler E, Geller T, Tamura RN, Krischer JP. Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer. Pediatr Blood Cancer 2015;62:1004–1010. PMID: 25545757.

7. Swota AH, Bradfield S. Eliciting parental values and preferences in the medical decision-making process. Am J Bioeth. 2015;15(5):34-5. doi: 10.1080/15265161.2015.1021978. PMID: 25970390.

8. Bechtel A, Cheek B, Bradfield S. False lung metastasis: Concurrent Ewing sarcoma and bronchoalveolar carcinoma. J Pediatr Hematol Oncol 2018; 40:325-7.  PMID: 29016412.

9. Agarwal V, Logie N, Morris CG, Bradley JA, Rotondo RL, Bradfield SM, Indelicato D, Esophagitis associated with multimodality management of pediatric Ewing sarcoma of thorax. Pediatr Blood Cancer 2018; 65, e27006. doi: 10.1002/ pbc.27006. PMID: 29431250.

10. Rutland MO, Egelund TA, Ng JS, Bradfield SM, Egelund EF. Intravenous and oral posaconazole pharmacokinetics in a five-year-old with mucor: A case report and review of the literature. J Pediatr Pharmacol Ther  2019;24:528-533.   doi:10.5863/1551-6776-24.6.528. PMID: 31719815.

11. Indelicato DJ, Rotondo RL, Mailhot Vega RB, Uezono H, Bradfield S, Agarwal V, Hol ML, Bradley JA. 45 GyRBE for

Group III Orbital Embryonal Rhabdomyosarcoma. Acta Oncol, 2019; 58(10):1404-9. doi:.10.1080/0284186X.2019.1627412. PMID: 31530120.

12. Kharod SM, Indelicato DJ, Rotondo RL, Mailhot Vega RB, Uezono H, Morris CG, Bradfield S, et al. Outcomes Following

 Proton Therapy for Ewing Sarcoma of the Cranium and Skull Base. Pediatr Blood Cancer 2020 Feb;67(2):e28080.   doi:10.1002/pbc.28080. PMID: 31736243.

13. Indelicato DJ, Rotondo RL, Krasin MJ, Mailhot Vega RB, Uezono H, Bradfield S, et al. Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2020 Apr 1;106(5):968-976.doi: 10.1016/j.ijrobp.2019.12.036. PMID: 31987977.

14. Schultz KAP, Nelson A, Harris AK, Finch M, Field A, Jarzembowski JA, Wilhelm M, …Bradfield S, et al. Pleuropulmonary blastoma-like peritoneal sarcoma; a newly described malignancy associated with biallelic DICER1 pathogenic variation. Mod Path 2020 Oct; 33:1922-9. doi: 10.1038/s41379-020-0558-4. PMID: 32415267.

15. Uezono H, Indelicato D, Rotondo RL, Mailhot Vega RB, Bradfield SM, Morris CG, Bradley JA .Treatment Outcomes after Proton Therapy for Ewing Sarcoma of the Pelvis. Int J Radiat Oncol Biol Phys 2020 Aug 1;107(5): 974-981. doi:10.1016/j.ijrobp.2020.04.043. PMID: 32437922.

16. Parekh AD, Indelicato DJ, Vega RBM, Rotondo RL, Morris CG, Bradfield S, Bradley JA. Proton radiotherapy for infant rhabdomyosarcoma: Rethinking young age as an adverse prognostic factor. Radiother Oncol 2021 May 21;163:215-220. doi:10.1016/j.radonc.2021.05.017. PMID: 34023329.

17. Johnston EE, Martinez I, Davis ES, Caudill C, et al.… on behalf of the POCC Consortium. [Bradfield SM, Member of POCC Consortium]. SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities. J Clin Onc 2021 Dec 1;39:3778-88. doi:10.1200/JCO.21.00702. PMID: 34694886.

18. Indelicato DJ, Vega RBM, Viviers E, Morris CG, Bradfield SM, Ranalli NJ, Bradley JA. Modern Therapy for Spinal and Paraspinal Ewing Sarcoma: An Update of the University of Florida Experience. Int J Radiat Oncol Biol Phys 2022 Jan13:S0360-3016(22)00017-7. doi: 10.1016/j.ijrobp.2022.01.007. PMID: 35033584.

19. Indelicato DJ, Mailhot Vega RB, Viviers E, Morris CG, Bradfield SM, Gibbs, Bradley JA. Modern Therapy for Chest Wall Ewing Sarcoma: An Update of the University of Florida Experience. Int J Radiat Oncol Biol Phys 2022 Feb 14:S0360-3016(22)00157-2. doi:10.1016/j.ijrobp.2022.02.011. PMID 35176415.

20. Metts J, Harrington B, Salman E, Bradfield SM, Flanary J, Mosha M, Amankwah E, Stapleton S. A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors. Childs Nerv Syst 2022 May;38(5):919-928. doi:10.1007/s00381-022-05479-7. PMID 35260913.

21. Shaw PH, Metts J, Amankwah E, Eslin DE, Bradfield S, Slayton WB, et al. Trends in Pediatric Cancer Care in Florida From 1981-2020: Changing Patterns in a Growing and Increasingly Diverse Population. Cureus. 2023 Feb 16:15(2): e35061. Doi:10.7759/cureus.35061. PMID 36938203.

22. Chalfant V, Riveros C, Bradfield SM, Stec AA. Impact of social disparities on 10 year survival rates in paediatric cancers: a cohort study. Lancet Reg Health Amer 2023 Apr; 20:100454. doi:10.1016/j.lana.2023.100454. PMID 36875264.

23. Vettese E, Sherani F, King AA, Yu L, Aftandilian C, Baggott C, Agarwal V, Nagasubramanian R, Kelly KM, Freyer DR, Orgel E, Bradfield SM, Kyono W, Roth M, Klesges LM, Beauchemin M, Grimes A, Tomlinson G, Dupuis LL, Sung L. Symptom management care pathway adaptation process and specific adaptation decisions. BMC Cancer. 2023;23(1):350. doi: 10.1186/s12885-023-10835-0. PMID 37069510.

24. Martin SD, Davis ES, Chen D, et al…on behalf of the POCC Consortium. [Bradfield SM, Member of POCC Consortium]. Clinical Features and Risk Factors Associated With Multisystem Inflammatory Syndrome in Children With Cancer and COVID-19. JAMA Onc 2023 May 11; e230525. doi:10.1001/jamaoncol.2023.0525. PMID: 37166782.

25. Chalfant V, Riveros C, Bechtel, A, Bradfield, SM, Stec AA.  Impact of social disparities on 5 year survival rates in pediatric hematological malignancies. Journal of Pediatric Hematology and Oncology, accepted for publication on Oct 6 2023.

BOOK CHAPTERS AND INVITED ARTICLES              

1. Bradfield SM, Neudorf  S, Rubin E, Sandler ES. Prevention and Treatment of Infectious Disease. In:  Kline RM. ed. Pediatric Hematopoietic Stem Cell Transplantation. 1^st ed. New York: Informa Healthcare; 2006, 27-63.

2. Bradfield SM. Adolescent and Young Adult Oncology: Addressing a Need. Northeast Florida Medicine. 2015;66(2):47-50.

1. Bradfield SM, Douglas JG, Hawkins DS, Sanders JE, Park JR.  Fractionated low-dose radiotherapy is an

effective mode of local control in high-risk neuroblastoma (Abstract #3239).  Proc Am Soc Clin Oncol, 2003; 22:806.

2. Bradfield SM, Loken MR, Radich JP. Letter to the Editor:  Graft-versus-leukemia effect in acute

lymphoblastic leukemia: The importance of tumor burden and early detection.  Leukemia 2004; 18: 1156-1158. PMID: 15042107.

3. Bradfield S, Hawkins DS, Whitlock J, Krailo M, Franklin J, Adamson PC, Children’s Oncology Group.

Phase II study of 21-day continuous intravenous infusion (CIVI) topotecan for recurrent pediatric solid

tumors: A Children’s Oncology Group Study (COG A09713) (Abstract #8523).  J Clin Oncol 2005;23,

supp 16S: 805s.

4. Eunpu DL, Bradfield S, Martin LS. An unusual presentation of Turner syndrome, ALL and TP53 in a 9 year old female.  American College of Medical Genetics, March 2010, Albuquerque, NM.

5. Stapleton  S, Hamblin  F, Steinbrueck S, Bradfield S, Tuite G, Carey C, Storrs B.  Feasibility of combination

 therapy with bevacizumab, irinotecan, and temozolomide in children with central nervous system tumors. (Abstract Control Number:2010-A-262-ISPNO), Accepted for 14th International Symposium on Pediatric Neuro-Oncology – ISPNO,

June 20 – 23, 2010, Vienna, Austria.

6. Swota AH, Bradfield SM. Letter to the Editor: When is State Intervention Justified? An Ethics Consult Gone Bad – Response.  Pediatr Blood Cancer 2010;54(7): 1055. PMID: 20222018.

7. Agarwal V, Logie N, Morris C, Bradley J, Rotondo R, Bradfield S, Indelicato DJ. Esophagitis in the Multimodality Treatment of Thoracic Ewing Sarcoma: Incidence, Risk Factors, and Management. American Society of Pediatric Hematology/Oncology Annual Meeting – ASPHO, April 26-29, 2017, Montreal, Canada.

8. Indelicato DJ, Rotondo RL, Mailhot R, Uezono H, Bradfield S, Agarwal V, Morris C, Bradley JA. Beware of pseudoprogression in group III pelvic rhabdomyosarcoma patients undergoing proton therapy for bladder preservation. Particle Therapy Co-operative Group Annual Meeting, Manchester, United Kingdom, June 2019.

9. Indelicato DJ, Rotondo RL, Mailhot R, Uezono H, Bradfield S, Agarwal V, Morris C, Bradley JA. Outcomes following proton therapy for group III pelvic rhabdomyosarcoma. Particle Therapy Co-operative Group Annual Meeting. Manchester, United Kingdom, June 2019.

10. Parekh A, Indelicato D, Mailhot Vega R, Rotondo R, Morris C, Bradfield S, Bradley J. Proton radiotherapy for infant rhabdomyosarcoma: Rethinking young age as an adverse prognostic factor. American Society for Radiation Oncology, Annual Meeting, Miami Beach, October 25 – 28, 2020.

11. Indelicato DJ, Mailhot Vega RB, Viviers E, Morris C, Bradfield S, Aldana PR, Bradley JA. Modern Therapy for Spinal and Paraspinal Ewing Sarcoma: an Update of the University of Florida Experience. 53^rd Congress of the International Society of Paediatric Oncology (SIOP), Virtual, October 21-24, 2021.

12. Johnson MC, Bradley JA, Mailhot Vega R, Bradfield S, Morris C, Indelicato. Outcomes in Pediatric NRSTS Treated with Proton Radiotherapy. 54^th Congress of the International Society of Paediatric Oncology (SIOP), Barcelona, Spain, September 29, 2022.

13. Giap F, Indelicato DJ, Mailhot Vega R, Morris C, Bradfield SM, Bradley JA. Local control for large unresectable intermediate risk pediatric rhabdomyosarcomas. American Society for Radiation Oncology, Annual Meeting, San Antonio, TX, October 23-26, 2022.

14. Fortune EC, Indelicato DJ, Mailhot Vega RB, Bradfield SM, Bradley JA. Outcomes following Proton Radiotherapy for Pediatric Salivary Gland Tumors. American Society for Radiation Oncology, Annual Meeting, San Antonio, TX, October 23-26, 2022.

1. “Graft vs. Host Disease,” Bone Marrow Transplant Conference, St. Luke’s Hospital, 11/11/05.

2. “Sinusoidal Obstruction Syndrome,” Bone Marrow Transplant RN Conference, Mayo Clinic, Jacksonville, 3/11/11.

3. Medical Director, 36^th Annual Seminar “Advances in Pediatric Hematology/Oncology” by the Florida Association

of Pediatric Tumor Programs. 11/7/13-11/9/13.

4. “Developing, nurturing, and growing a mature, healthy, adolescent and young adult…program,” 37^th Annual Seminar “Advances in Pediatric Hematology/Oncology” by the Florida Association of Pediatric Tumor Programs. 10/25/2014.

5. “Orthopedic Manifestations of Pediatric Leukemias/Lymphomas,” Nemours Children’s Specialty Care Orthopedic Grand Rounds, 3/4/15.

6. “Vascular and Lymphatic Malformations in Children,” Baptist Hospital CME presentation, 4/20/21.